Bennett Murphy - AmerisourceBergen VP Relations
| ABG Stock | EUR 234.55 0.10 0.04% |
Insider
Bennett Murphy is VP Relations of AmerisourceBergen
| Phone | 610 727 7000 |
| Web | https://www.amerisourcebergen.com |
AmerisourceBergen Management Efficiency
The company has return on total asset (ROA) of 0.0294 % which means that it generated a profit of $0.0294 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.502 %, meaning that it generated $0.502 on every $100 dollars invested by stockholders. AmerisourceBergen's management efficiency ratios could be used to measure how well AmerisourceBergen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Craig Cowman | Cardinal Health | N/A | |
| Ronald Lombardi | Prestige Consumer Healthcare | 59 | |
| Graham Stanley | Henry Schein | N/A | |
| Jeffrey Zerillo | Prestige Consumer Healthcare | 62 | |
| Dawei Ge | Shanghai Pharmaceuticals Holdin | 56 | |
| Jessica Mayer | Cardinal Health | 53 | |
| William PPool | Prestige Consumer Healthcare | 58 | |
| Ying Ke | Shanghai Pharmaceuticals Holdin | N/A | |
| John Wright | Patterson Companies | N/A | |
| Mary Scherer | Cardinal Health | N/A | |
| Michael Ettinger | Henry Schein | 62 | |
| Xiaojuan Li | Sinopharm Group Co | 47 | |
| James Breslawski | Henry Schein | 69 | |
| Shui ACS | Shanghai Pharmaceuticals Holdin | 46 | |
| Stanley Bergman | Henry Schein | 73 | |
| Deborah Weitzman | Cardinal Health | N/A | |
| Min Zuo | Shanghai Pharmaceuticals Holdin | 57 | |
| Shunjiang Yu | Shanghai Pharmaceuticals Holdin | N/A | |
| Stephen Mason | Cardinal Health | 51 | |
| Jianyi Mao | Shanghai Pharmaceuticals Holdin | 50 | |
| Jun Zhou | Shanghai Pharmaceuticals Holdin | 50 | |
Management Performance
| Return On Equity | 0.5 | |||
| Return On Asset | 0.0294 |
AmerisourceBergen Leadership Team
Elected by the shareholders, the AmerisourceBergen's board of directors comprises two types of representatives: AmerisourceBergen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AmerisourceBergen. The board's role is to monitor AmerisourceBergen's management team and ensure that shareholders' interests are well served. AmerisourceBergen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AmerisourceBergen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| PharmD Mauch, Ex COO | ||
| Steven Collis, Pres Chairman | ||
| Kathy Gaddes, Ex Officer | ||
| James Cleary, Ex CFO | ||
| Elizabeth Campbell, Ex Officer | ||
| Bennett Murphy, VP Relations | ||
| Silvana Battaglia, Ex Officer | ||
| Lazarus Krikorian, Chief VP | ||
| John Chou, Ex CEO | ||
| Gina Clark, Exec Officer |
AmerisourceBergen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AmerisourceBergen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.5 | |||
| Return On Asset | 0.0294 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 33.88 B | |||
| Shares Outstanding | 202.26 M | |||
| Shares Owned By Insiders | 16.95 % | |||
| Shares Owned By Institutions | 77.85 % | |||
| Price To Earning | 17.93 X | |||
| Price To Book | 5.05 X |
Currently Active Assets on Macroaxis
Other Information on Investing in AmerisourceBergen Stock
AmerisourceBergen financial ratios help investors to determine whether AmerisourceBergen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AmerisourceBergen with respect to the benefits of owning AmerisourceBergen security.